https://www.selleckchem.com/products/tak-779.html
Surfactant protein C (SP-C) dysfunction is a rare disease associated with interstitial lung disease. Early therapies may improve outcomes but the diagnosis is often delayed owing to variability of manifestations. To investigate the manifestations and outcomes of SP-C dysfunction. We retrospectively analyzed the records of five pediatric patients who were diagnosed with SP-C dysfunction between February 2014 and April 2017 at Beijing Children's Hospital. The five patients included two boys and three girls with a median age at diagnosis o
Мне нравится
Комментарий
Перепост
